# Influencing Factors of Delayed Diagnosis of COVID-19 in Gangwon, South Korea

**Authors:** Minhye Park, Seungmin Jeong, Yangjun Park, Saerom Kim, Yeojin Kim, Eunmi Kim, So Yeon Kong

PMC · DOI: 10.3390/ijerph21050641 · International Journal of Environmental Research and Public Health · 2024-05-17

## TL;DR

This study identifies factors contributing to delayed diagnosis of COVID-19 in Gangwon, South Korea, and highlights the need for improved testing systems.

## Contribution

The study provides insights into specific demographic and situational factors linked to delayed diagnosis of COVID-19 in a regional context.

## Key findings

- 21.8% of patients were diagnosed within a day of symptom onset.
- Older age and nonworkday symptom onset were associated with increased delayed diagnosis risks.
- Promotion and system adjustments are needed for prompt testing upon symptom recognition.

## Abstract

This study aimed to identify the time to diagnosis among COVID-19 patients and factors associated with delayed diagnosis (DD). Data from COVID-19 patients in Gangwon, South Korea, diagnosed between 22 February 2020 and 29 January 2022, were analyzed, excluding asymptomatic cases and those who underwent mandatory testing. DD was defined as a period exceeding 2 or more days from symptom recognition to COVID-19 diagnosis. Univariate analysis was performed to investigate the demographic characteristics, COVID-19 symptoms, and underlying medical conditions associated with DD, followed by multivariate logistic regression analysis for significant variables. Among 2683 patients, 584 (21.8%) were diagnosed within a day of symptom onset. DD rates were lower in patients with febrile symptoms but higher among those with cough, myalgia, or anosmia/ageusia. High-risk underlying medical conditions were not significantly associated with DD. Older age groups, the Wonju medical service area, time of diagnosis between November 2020 and July 2021, symptom onset on nonworkdays, and individuals in nonwhite collar sectors were significantly associated with increased DD risks. These findings were consistent in the sensitivity analysis. This study underscores the need for enhanced promotion and system adjustments to ensure prompt testing upon symptom recognition.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** anosmia (MESH:D000857), myalgia (MESH:D063806), febrile symptoms (MESH:D012816), cough (MESH:D003371), COVID-19 (MESH:D000086382), ageusia (MESH:D000370)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11121085/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC11121085/full.md

---
Source: https://tomesphere.com/paper/PMC11121085